Between 2001 and 2012 the number of heart attack deaths halved, but cancer mortality continues to rise. The Office of National Statistics (ONS) has published new mortality data for the UK.
Deaths from heart attacks and strokes nearly halved in England and Wales over the first decade of the century. The figures show 46,610 people died of a heart attack in 2001, falling to 23,085 last year, while stroke deaths fell from 33,918 to 17,024. Better diets, a reduction in smoking, and effective treatment are behind the decrease in mortality.
The statistics also revealed the unusual, and accidental, causes of death in the UK over the same period. Three deaths, all male, due to snake bites were recorded, one man died of dengue fever, and four men and two women died of anthrax poisoning.
Heart disease was the biggest killer in the UK, causing the deaths of 40,557 people in 2012 alone. Lung cancer was identified as the second biggest killer, causing over 30,000 deaths, followed by “unspecified dementia”.
Last year, for the first time, deaths attributed to cancer or neoplasms (tumours) exceeded those caused by circulatory disease. Circulatory disease, which includes heart attacks and strokes, has so far been the biggest killer this century, responsible for a total of 2,114,550 deaths so far while cancers and neoplasms accounted for 1,686,133.
Looking back at ONS data from the 20th century you can see how the leading causes of death have shifted away from infectious diseases. Before antibiotics, bronchitis, pneumonia and TB were among the biggest killers.
The Guardian has illustrated the data in an interactive chart: How people have died in the 21st century.
Dr Markowitz has also seen the value of transfer factor therapy for an eleven-year-old boy with lymphoblastic leukemia. After chemotherapy and a bone marrow transplant, he still experienced a relapse, and his leukemia actually became more severe. Enhanced transfer factor supplements were used in combination with chemotherapy treatments, and the results have been very encouraging. Supplementing chemotherapy with transfer factor appeared to support the boy’s immune system and prevent the infections that usually take hold during treatment. His doctors believe that his supplementation with transfer factors most likely spared him the life-threatening complications of infectious disease and apparently improved his tolerance of a very toxic course of chemotherapy.
FACT: One in every three Americans will develop cancer. 1.2 million cancer cases are diagnosed every year in this country, and that number is going up, not down. Of these, six of ten people will die within five years.
FACT: One in every four deaths (over 500,00 each year) is attributable to cancer, and the rate is rising. The good news is that the National Cancer Institute estimates that over 75% of all cancer cases are preventable.
FACT: According to some experts at the National Cancer Institute, we are losing our battle with cancer because we’ve been on the wrong track. Prevention rather than cure should become our new emphasis.
What is cancer? It is a disease characterized by the uncontrolled growth of abnormal cells permitted to reproduce due to extensive immune collapse. Cancer is allowed to grow because our immune surveillance system falls asleep.
Our immune watch guards single out identify and destroy carcinogenic agents that enter the body daily. Immune cells such as B-lymphocytes produce antibodies designed to attack and eradicate malignant cells, and a variety of immune chemicals keep tumors in check.
Given the multifaceted defense strategy of our immune system, it is remarkable that in some people, cancer cells grow without any detection. Why? Because people with faulty immune responses are at a much higher risk of developing cancer.
Because many of us cannot avoid exposure to pollution, pesticides, additives, ultra-violet rays, etc., it is crucial that we boost our natural immune defenses to protect us against cancer.
Transfer Factor as a Support to Chemotherapy
Cancer patients who are undergoing chemotherapy or radiation which greatly weaken the immune system, can greatly benefit from taking transfer factor supplementation. Transfer factor supplementation serves to protect the body from “opportunistic” infections, which often occur during these treatments.
Dr Duane Townsend, former director of gynecologic oncology at LDS Hospital in Salt Lake City, puts all of his cancer patients on transfer factor treatments to boost their immune systems’ abilities to respond to any health challenges.
Both Japanese and Chinese clinical studies found that the immunosuppression that results from chemotherapy can be prevented by using transfer factor isolates. Keep in mind that the elimination of dying or dead cancer cells is monitored by the immune system. Italian, Japanese and American studies tell us that the use of transfer factor isolates to boost immune function after surgery significantly improves the chances of cancer-free future.